TreatSMA

TreatSMA Families make final plea inside and outside NICE

Thank you to all those that travelled to attend our vigil yesterday outside NICE in Manchester.

As well as being very cold and windy it was very emotional and overwhelming as well. The patient experts speaking inside could not have represented us better as a community. The clinicians also spoke with nothing but passion for the UK SMA population and fought our corner hard.

The Chair of the NICE committee that discussed Spinraza yesterday came down and introduced himself to those outside, so our presence was acknowledged and felt. The children were amazing.

Please see pictures of the day attached.

Thank you everyone.

Latest Posts

Calling on all the community to ACT NOW to avoid losing treatments!
Currently, there are two approved treatments for SMA: risdiplam and nusinersen. These treatments were initially approved temporarily under Managed Access Agreements while the NHS and NICE gathered data to assess their cost-effectiveness. Now, as these agreements come to an end, both treatments face a crucial review.
Read more
NICE’s upcoming Multi Technology Assessment for Spinraza and Risdiplam
SMA UK are proud to join together with Treat SMA and MDUK to bring you this webinar about NICE’s upcoming Multi Technology Assessment for Spinraza and Risdiplam. 2024 sees the end of the managed access agreements (MAAs) for the two treatments. An expert committee will gather to assess the new clinical and real-world evidence, along…
Read more
Let the battle begin
This year the Managed Access Agreement for Spinraza and Risdiplam expires. The MAA was put in place five years ago so the pharmaceutical companies could gather more evidence to resubmit to NICE for approval on the NHS with Biogen extending their MAA by a year.
Read more